| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |